In 2023, hospital discharges for malignant neoplasm of the ovary in Germany amounted to approximately 25.3 thousand. The forecasted data shows a declining trend from 2024, with expected discharges decreasing annually from 24.72 thousand to 22.4 thousand by 2028. This indicates a general downward trajectory in hospital discharges over this period.

Future trends to watch for include:

Advancements in early detection and treatment of ovarian neoplasms, potentially leading to fewer hospitalizations.
Changes in healthcare policies and funding that may affect hospital discharge rates.
The impact of demographic shifts, such as aging populations, on the prevalence of ovarian cancer and corresponding hospital discharges.